RIV-1029

N/A

Report date: 2025/01/26 19:35:35
NME

Base Information

Drug NameRIV-1029
Drug Alias NameRIV-1029
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric oxide donors
TargetsUpdating
Therapy Area/IndicationsCognition DisordersAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRevivo Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesRevivo Therapeutics
Inactive CompaniesN/A
Active IndicationsCognition DisordersAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A